IDEX (IEX) AI Stock Analysis

• Market Cap: $12.83B
• Dividend Yield: 1.64%
• Average Volume (3M): 632.80K
• Price to Earnings (P/E): 27.1
• Beta (1Y): 1.01
• Revenue Growth: 7.09%
• EPS Growth: -2.29%
• Country: US
• Employees: 9,000
• Sector: Industrials
• Sector Strength: 72
• Industry: Industrial - Machinery
• EPS (TTM): 2.03
• Shares Outstanding: 74,849,434
• 10 Day Avg. Volume: 675,223
• 30 Day Avg. Volume: 632,803
• PEG Ratio: -2.04
• Price to Book (P/B): 4.18
• Price to Sales (P/S): 4.85
• P/FCF Ratio: 26.27
• Enterprise Value/Market Cap: 1.06
• Enterprise Value/Revenue: 3.97
• Enterprise Value/Gross Profit: 9.13
• Enterprise Value/Ebitda: 15.34
• 1Y Price Target: $191.00
• Price Target Upside: 11.40% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 7

• Rating: 75 Outperform
• Price Target: $195.00 ▲(13.73% Upside)

IDEX's strong earnings performance and strategic focus on growth through acquisitions and shareholder returns are significant positives. The company's solid financial health and positive technical indicators support its outlook, although the high valuation and macroeconomic challenges present some risks.

Positive Factors

Strong Cash Flow Management

IDEX's ability to convert a high percentage of its net income into free cash flow indicates strong cash generation, which supports reinvestment and shareholder returns.

Record Performance in HST Segment

The record performance in the HST segment highlights IDEX's strength in health and science technologies, supporting long-term growth and market leadership.

Successful Acquisitions

Successful integration of acquisitions enhances IDEX's product offerings and market reach, driving sustainable growth and competitive advantage.

Negative Factors

Pressure on Operating Margins

Decreasing operating margins suggest challenges in maintaining cost efficiency, which could impact profitability if not addressed.

Decline in FSDP Segment

The decline in the FSDP segment indicates potential weaknesses in product demand, which could hinder overall revenue growth if not mitigated.

Macroeconomic Challenges

Ongoing macroeconomic challenges pose risks to IDEX's operations, potentially impacting sales and profitability across affected segments.

IDEX Business Overview & Revenue Model

Company Description

IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries. The HST segment designs, produces, and distributes precision fluidics, rotary lobe pumps, centrifugal and positive displacement pumps, roll compaction and drying systems, pneumatic components and sealing solutions, high performance molded and extruded sealing components, custom mechanical and shaft seals, engineered hygienic mixers and valves, biocompatible medical devices and implantables, air compressors and blowers, optical components and coatings, laboratory and commercial equipment, precision photonic solutions, and precision gear and peristaltic pump technologies. This segment serves food and beverage, pharmaceutical and biopharmaceutical, cosmetics, marine, chemical, wastewater and water treatment, life sciences, research, and defense markets. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, rescue tools, lifting bags, and other components and systems for the fire and rescue industry; engineered stainless steel banding and clamping devices for various industrial and commercial applications; and precision equipment for dispensing, metering, and mixing colorants and paints used in retail and commercial businesses. IDEX Corporation was incorporated in 1987 and is headquartered in Northbrook, Illinois.

How the Company Makes Money

IDEX generates revenue through multiple key streams, primarily by selling a diverse portfolio of products and solutions across its various business segments. The company earns money through direct sales of its engineered products, including pumps, valves, and flow measurement devices, which are utilized in critical processes across various industries. Additionally, IDEX benefits from recurring revenue through maintenance and service contracts associated with its products. Significant partnerships with other industrial firms and suppliers enhance its market reach and product offerings, allowing IDEX to capitalize on emerging market trends. Furthermore, IDEX invests in research and development, which helps maintain its competitive edge and drive innovation, further contributing to its revenue growth.

IDEX Financial Statement Overview

Summary

IDEX demonstrates solid financial health with consistent revenue growth and strong operational margins. The balance sheet is stable with low leverage, and cash flows are generally healthy despite recent declines in free cash flow. Continued focus on cost management and cash flow improvement will be crucial for sustaining growth.

Income Statement

IDEX shows consistent revenue growth with a TTM increase of 2.41%, despite a slight decline in gross and net profit margins compared to previous years. The EBIT and EBITDA margins remain strong, indicating operational efficiency. However, the slight decrease in net income suggests potential cost pressures.

Balance Sheet

The company maintains a healthy balance sheet with a low debt-to-equity ratio of 0.47 in the TTM, indicating strong financial stability. Return on Equity (ROE) is solid at 12.16%, reflecting effective use of equity. The equity ratio is robust, showcasing a strong asset base relative to liabilities.

Cash Flow

Operating cash flow remains strong with a coverage ratio of 1.14, indicating good cash generation relative to net income. However, the negative free cash flow growth rate of -49.4% in the TTM is a concern, suggesting potential cash management issues or increased capital expenditures.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	3.42B	3.27B	3.27B	3.18B	2.76B	2.35B
Gross Profit	1.49B	1.52B	1.62B	1.59B	1.36B	1.16B
EBITDA	884.70M	859.40M	964.10M	909.80M	720.50M	604.60M
Net Income	478.10M	505.00M	596.10M	586.90M	449.40M	377.80M
Balance Sheet
Total Assets	6.97B	6.75B	5.87B	5.51B	4.92B	4.41B
Cash, Cash Equivalents and Short-Term Investments	593.80M	620.80M	534.30M	430.20M	900.70M	1.03B
Total Debt	1.90B	1.99B	1.45B	1.59B	1.30B	1.16B
Total Liabilities	2.96B	2.95B	2.32B	2.47B	2.11B	1.87B
Stockholders Equity	4.01B	3.79B	3.54B	3.04B	2.80B	2.54B
Cash Flow
Free Cash Flow	584.10M	603.00M	626.80M	489.40M	492.60M	517.70M
Operating Cash Flow	643.50M	668.10M	716.70M	557.40M	565.30M	569.30M
Investing Cash Flow	-134.70M	-1.01B	-283.80M	-917.20M	-698.10M	-172.60M
Financing Cash Flow	-565.70M	465.90M	-344.70M	-37.80M	-9.50M	-42.60M

IDEX Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 171.46
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IEX, the sentiment is Positive. The current price of 171.46 is above the 20-day moving average (MA) of 166.56, above the 50-day MA of 164.01, and below the 200-day MA of 177.03, indicating a neutral trend. The MACD of 1.96 indicates Negative momentum. The RSI at 60.55 is Neutral, neither overbought nor oversold. The STOCH value of 41.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IEX.

IDEX Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ITT	―	$14.44B	30.75	17.85%	0.70%	8.01%	2.67%
CR	―	$10.94B	34.33	18.09%	0.47%	-0.37%	21.77%
NDSN	―	$13.03B	29.16	15.59%	1.36%	4.49%	-3.33%
IEX	―	$12.83B	27.11	12.21%	1.64%	7.09%	-2.29%
GGG	―	$13.56B	27.94	19.45%	1.35%	2.85%	3.09%
GNRC	―	$9.86B	31.97	12.38%	―	5.52%	9.03%
Sector *	―	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%

IDEX Corporate Events

IDEX Corporation Reports Strong Q3 2025 Results

IDEX Corporation, a global company specializing in engineered products and mission-critical components, operates in sectors such as healthcare, water treatment, and fire safety. In its latest earnings report for the third quarter of 2025, IDEX Corporation announced record sales of $879 million, marking a 10% increase from the previous year. The company also reported a rise in diluted earnings per share (EPS) to $1.70, with adjusted EPS reaching $2.03. Record orders were noted at $880 million, reflecting a 13% increase. IDEX has narrowed its full-year EPS outlook and increased its share repurchase authorization to $1 billion.

IDEX Expands Share Repurchase Program to $1 Billion

On September 18, 2025, IDEX Corporation announced an increase in its share repurchase authorization to $1 billion, reflecting confidence in its growth strategy and strong free cash flow generation. The company plans to return at least 70% of its free cash flow to shareholders through dividends and share repurchases in 2025, while also investing in growth opportunities and acquisitions. Additionally, IDEX declared a regular quarterly cash dividend of $0.71 per share, to be paid on October 24, 2025, marking its 124th consecutive quarterly dividend payment.

The most recent analyst rating on (IEX) stock is a Buy with a $179.00 price target. To see the full list of analyst forecasts on IDEX stock, see the IEX Stock Forecast page.

IDEX Corporation Reports Strong Q2 Sales Amid EPS Decline

IDEX Corporation is a global company that designs and manufactures engineered products and components, primarily serving the industrial sector with a diverse range of solutions including precision components for electronics, water treatment, and fire and rescue tools.

IDEX Corporation’s Earnings Call Highlights Mixed Outlook

IDEX Corporation’s recent earnings call revealed a mixed sentiment, reflecting both strong performance and cautious outlooks. The company showcased robust Q2 financial results and strategic growth initiatives, yet adjusted its guidance for the latter half of 2025 due to slower decision-making and weaker demand in certain segments, including semiconductor and automotive. While confident in its long-term growth potential, IDEX is mindful of immediate challenges.